Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oligodendroglia | 8 | 2022 | 36 | 2.300 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 8 | 2021 | 61 | 1.980 |
Why?
|
| Interferon Regulatory Factor-1 | 5 | 2012 | 10 | 1.830 |
Why?
|
| Multiple Sclerosis | 7 | 2022 | 94 | 1.090 |
Why?
|
| Interferon-gamma | 4 | 2012 | 76 | 0.960 |
Why?
|
| Myelin Sheath | 4 | 2022 | 24 | 0.750 |
Why?
|
| Apoptosis | 3 | 2010 | 193 | 0.630 |
Why?
|
| Mice | 11 | 2022 | 1280 | 0.610 |
Why?
|
| Animals | 14 | 2022 | 3386 | 0.600 |
Why?
|
| Demyelinating Diseases | 2 | 2022 | 12 | 0.580 |
Why?
|
| Neuromyelitis Optica | 2 | 2019 | 7 | 0.580 |
Why?
|
| Signal Transduction | 4 | 2020 | 388 | 0.510 |
Why?
|
| Cell Differentiation | 3 | 2022 | 124 | 0.470 |
Why?
|
| Aquaporin 4 | 2 | 2019 | 7 | 0.460 |
Why?
|
| Inflammation | 2 | 2012 | 263 | 0.440 |
Why?
|
| Aquaporins | 1 | 2012 | 7 | 0.420 |
Why?
|
| Escherichia coli Proteins | 1 | 2012 | 10 | 0.410 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2011 | 2 | 0.370 |
Why?
|
| Immunomodulation | 1 | 2011 | 6 | 0.370 |
Why?
|
| Neuroglia | 1 | 2011 | 41 | 0.360 |
Why?
|
| Immunologic Factors | 3 | 2019 | 32 | 0.360 |
Why?
|
| Cells, Cultured | 6 | 2020 | 475 | 0.360 |
Why?
|
| STAT1 Transcription Factor | 1 | 2010 | 2 | 0.350 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2007 | 4 | 0.340 |
Why?
|
| Stem Cells | 1 | 2010 | 39 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 5 | 2022 | 371 | 0.330 |
Why?
|
| Natalizumab | 2 | 2019 | 17 | 0.330 |
Why?
|
| Mice, Transgenic | 4 | 2012 | 200 | 0.310 |
Why?
|
| Repressor Proteins | 1 | 2006 | 25 | 0.260 |
Why?
|
| Carrier Proteins | 1 | 2006 | 79 | 0.260 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2019 | 23 | 0.250 |
Why?
|
| Th17 Cells | 2 | 2021 | 27 | 0.230 |
Why?
|
| Wound Healing | 1 | 2005 | 146 | 0.230 |
Why?
|
| Central Nervous System | 3 | 2010 | 54 | 0.210 |
Why?
|
| Cardiac Glycosides | 1 | 2022 | 1 | 0.210 |
Why?
|
| Filgrastim | 2 | 2019 | 5 | 0.210 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2021 | 1 | 0.190 |
Why?
|
| Interleukin-17 | 1 | 2021 | 18 | 0.190 |
Why?
|
| Female | 10 | 2022 | 14347 | 0.190 |
Why?
|
| Caspase 1 | 2 | 2012 | 16 | 0.180 |
Why?
|
| Flow Cytometry | 2 | 2011 | 109 | 0.180 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2020 | 15 | 0.180 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2020 | 22 | 0.170 |
Why?
|
| Mice, Knockout | 2 | 2011 | 265 | 0.170 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 122 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 568 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 112 | 0.150 |
Why?
|
| JC Virus | 1 | 2019 | 82 | 0.150 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2019 | 99 | 0.140 |
Why?
|
| Humans | 10 | 2021 | 25964 | 0.140 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 199 | 0.140 |
Why?
|
| Pericytes | 2 | 2007 | 7 | 0.130 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 5 | 0.100 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2012 | 8 | 0.100 |
Why?
|
| Cross Reactions | 1 | 2012 | 11 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2012 | 57 | 0.100 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 132 | 0.100 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 162 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2010 | 151 | 0.100 |
Why?
|
| Rabbits | 1 | 2012 | 180 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 87 | 0.100 |
Why?
|
| Male | 7 | 2020 | 13980 | 0.100 |
Why?
|
| Electrophoresis | 1 | 2011 | 5 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 119 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2011 | 50 | 0.090 |
Why?
|
| Rats | 2 | 2010 | 598 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 335 | 0.090 |
Why?
|
| Janus Kinases | 1 | 2010 | 1 | 0.090 |
Why?
|
| eIF-2 Kinase | 1 | 2010 | 7 | 0.090 |
Why?
|
| Cell Death | 1 | 2010 | 43 | 0.090 |
Why?
|
| DNA | 1 | 2010 | 93 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2010 | 79 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 109 | 0.080 |
Why?
|
| Adult | 5 | 2020 | 7349 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 119 | 0.080 |
Why?
|
| Middle Aged | 4 | 2019 | 8507 | 0.080 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2007 | 7 | 0.070 |
Why?
|
| Chemokines | 1 | 2007 | 21 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2007 | 44 | 0.070 |
Why?
|
| Antibody Formation | 1 | 2007 | 18 | 0.070 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2006 | 1 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2007 | 82 | 0.070 |
Why?
|
| Cell Survival | 1 | 2006 | 111 | 0.070 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2005 | 6 | 0.060 |
Why?
|
| Prostaglandin D2 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2005 | 9 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2005 | 159 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 149 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 254 | 0.050 |
Why?
|
| Models, Biological | 1 | 2005 | 304 | 0.050 |
Why?
|
| Cuprizone | 1 | 2022 | 1 | 0.050 |
Why?
|
| Digoxin | 1 | 2022 | 2 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2022 | 5 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2021 | 26 | 0.050 |
Why?
|
| Interleukin-23 | 1 | 2020 | 16 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2020 | 35 | 0.040 |
Why?
|
| Protein Binding | 1 | 2020 | 113 | 0.040 |
Why?
|
| Cytokines | 1 | 2021 | 226 | 0.040 |
Why?
|
| Antilymphocyte Serum | 1 | 2019 | 3 | 0.040 |
Why?
|
| Hematologic Agents | 1 | 2019 | 3 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2019 | 4 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 1361 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 49 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2019 | 36 | 0.040 |
Why?
|
| Rituximab | 1 | 2019 | 50 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 158 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2019 | 71 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 306 | 0.040 |
Why?
|
| Disease Progression | 1 | 2019 | 685 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1140 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 1848 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3288 | 0.020 |
Why?
|
| Plasma | 1 | 2010 | 17 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 49 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 49 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2010 | 34 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2010 | 52 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 73 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 1642 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 68 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 457 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 485 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 547 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 30 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2010 | 1815 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 317 | 0.010 |
Why?
|